Cargando…

Effects of liraglutide on diastolic function parameters in patients with type 2 diabetes and coronary artery disease: a randomized crossover study

BACKGROUND: Diastolic dysfunction is highly prevalent in patients with type 2 diabetes mellitus (T2DM) and is associated with overweight, glucose dysregulation and coronary artery disease (CAD). The GLP-1 receptor agonist, liraglutide, has shown to induce weight loss and improve metabolic factors, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumarathurai, Preman, Sajadieh, Ahmad, Anholm, Christian, Kristiansen, Ole P., Haugaard, Steen B., Nielsen, Olav W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791686/ https://www.ncbi.nlm.nih.gov/pubmed/33413428 http://dx.doi.org/10.1186/s12933-020-01205-2

Ejemplares similares

Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study
por: Kumarathurai, Preman, et al.
Publicado: (2016)

Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol
por: Anholm, Christian, et al.
Publicado: (2014)

Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease
por: Anholm, Christian, et al.
Publicado: (2019)

Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial
por: Pedersen, Lene Rørholm, et al.
Publicado: (2019)

P‐wave indices as predictors of atrial fibrillation
por: Rasmussen, Maria Uggen, et al.
Publicado: (2020)

High-sensitivity C-reactive protein and exercise-induced changes in subjects suspected of coronary artery disease
por: Mouridsen, Mette Rauhe, et al.
Publicado: (2014)

Hyperoxia-induced deterioration of diastolic function in anaesthetised patients with coronary artery disease – Randomised crossover trial
por: Friess, Jan O., et al.
Publicado: (2023)

Effects of vitamins K2 and D3 supplementation in patients with severe coronary artery calcification: a study protocol for a randomised controlled trial
por: Hasific, Selma, et al.
Publicado: (2023)

Parasympathetic tonus in type 2 diabetes and pre-diabetes and its clinical implications
por: Hadad, Rakin, et al.
Publicado: (2022)

Predictors and 3‐year outcomes of compromised left circumflex coronary artery after left main crossover stenting
por: Ullah, Hameed, et al.
Publicado: (2021)

Donor artery stenosis interactions with diastolic blood pressure on coronary collateral flow in type 2 diabetic patients with chronic total occlusion
por: Shen, Ying, et al.
Publicado: (2018)

Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet
por: Sukumaran, Vijayakumar, et al.
Publicado: (2020)

Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol
por: Pedersen, Lene Rørholm, et al.
Publicado: (2013)

Association between intrarenal arterial resistance and diastolic dysfunction in type 2 diabetes
por: MacIsaac, Richard J, et al.
Publicado: (2008)

Modulating Crossover Frequency and Interference for Obligate Crossovers in Saccharomyces cerevisiae Meiosis
por: Chakraborty, Parijat, et al.
Publicado: (2017)

Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
por: Rizzo, Manfredi, et al.
Publicado: (2016)

Diastolic Coronary Artery Compression in Constrictive Pericarditis
por: Christopoulos, Georgios, et al.
Publicado: (2020)

The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study
por: Wang, Jin, et al.
Publicado: (2022)

Long-Term Exposure to Road Traffic Noise and Nitrogen Dioxide and Risk of Heart Failure: A Cohort Study
por: Sørensen, Mette, et al.
Publicado: (2017)

Variation in Crossover Frequencies Perturb Crossover Assurance Without Affecting Meiotic Chromosome Segregation in Saccharomyces cerevisiae
por: Krishnaprasad, Gurukripa N., et al.
Publicado: (2015)

Effect of Percutaneous Coronary Intervention on Diastolic Function in Coronary Artery Disease
por: Aggarwal, Puneet, et al.
Publicado: (2021)

Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
por: Jendle, J., et al.
Publicado: (2021)

Phasic Diastolic Coronary Artery Compression: A Rare Cause of Chest Pain at Rest
por: Gambril, John A, et al.
Publicado: (2023)

Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study
por: Yamada, Hirotsugu, et al.
Publicado: (2017)

Decreased diastolic wall strain is associated with adverse left ventricular remodeling even in patients with normal left ventricular diastolic function
por: Kang, Min-Kyung, et al.
Publicado: (2014)

Coronary microvascular function, insulin sensitivity and body composition in predicting exercise capacity in overweight patients with coronary artery disease
por: Jürs, Anders, et al.
Publicado: (2015)

Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis
por: Bruen, Robyn, et al.
Publicado: (2017)

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics
por: Htoo, Phyo T., et al.
Publicado: (2022)

Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes – a randomized, single-blinded, cross-over pilot study
por: Faber, Rebekka, et al.
Publicado: (2015)

Pericardial fat and its influence on cardiac diastolic function
por: de Wit-Verheggen, Vera H. W., et al.
Publicado: (2020)

The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial
por: Samkani, Amirsalar, et al.
Publicado: (2018)

Estimating the rates of crossover and gene conversion from individual genomes
por: Setter, Derek, et al.
Publicado: (2022)

The paramount parameter: arterial oxygen tension versus arterial oxygen saturation as target in trials on oxygenation in intensive care
por: Schjørring, Olav Lilleholt, et al.
Publicado: (2018)

Correlation Between Diastolic Dysfunction and Coronary Artery Disease on Coronary Computed Tomography Angiography
por: Jamiel, Abdelrahman, et al.
Publicado: (2016)

Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone
por: Sullivan, Sean D, et al.
Publicado: (2009)

The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis
por: Kushima, Hideki, et al.
Publicado: (2017)

Liraglutide preserves CD34(+) stem cells from dysfunction Induced by high glucose exposure
por: Sforza, Annalisa, et al.
Publicado: (2022)

Long‐term outcomes in patients with normal coronary arteries, nonobstructive, or obstructive coronary artery disease on invasive coronary angiography
por: Hanson, Christopher A., et al.
Publicado: (2021)

Echocardiographic subtypes of heart failure in consecutive hospitalised patients with dyspnoea
por: Nielsen, Olav Wendelboe, et al.
Publicado: (2019)

Fine-Scale Crossover Rate Variation on the Caenorhabditis elegans X Chromosome
por: Bernstein, Max R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2rjfputgmd1i8qjhgmg7vph1ng